Previous 10 | Next 10 |
2024-05-14 06:59:46 ET Summary Patients on Novo Nordisk's obesity drug Wegovy maintained an average of 10% weight loss over four years. Walmart reportedly plans to lay off corporate jobs and relocate remote workers to central hubs. Uber is acquiring Delivery Hero's foodpanda b...
2024-05-14 04:32:51 ET More on Novo Nordisk FTC Cracks Down On Novo Nordisk's Ozempic Novo Nordisk 2024 Q1 - Earnings Call Presentation Novo Nordisk (NVO) Q1 2024 Earnings Call Transcript Novo Nordisk hemophilia candidate Mim8 meets primary goals in phase 3 t...
2024-05-13 14:28:09 ET More on Novo Nordisk The FTC Cracks Down On Novo Nordisk's Ozempic Novo Nordisk A/S 2024 Q1 - Results - Earnings Call Presentation Novo Nordisk A/S (NVO) Q1 2024 Earnings Call Transcript BoA raises 2024 Novo Nordisk Wegovy sales estimat...
2024-05-13 11:48:17 ET More on Novo Nordisk The FTC Cracks Down On Novo Nordisk's Ozempic Novo Nordisk A/S 2024 Q1 - Results - Earnings Call Presentation Novo Nordisk A/S (NVO) Q1 2024 Earnings Call Transcript U.S. dialysis volumes expected to rebound in 2024...
2024-05-12 13:25:00 ET Many billionaire investors are going all in on artificial intelligence (AI). That's understandable. AI is quickly being integrated into businesses' day-to-day operations. The leaders in the field could deliver outsized returns. However, there are other exciting invest...
2024-05-12 05:43:33 ET Summary Viking Therapeutics' subcutaneously administered version of VK2735 has generated competitive data in the phase 2 trial in obese patients. The oral formulation of VK2735 reported good tolerability that leaves room for exploration of higher doses. ...
2024-05-11 12:13:54 ET More on Fresenius Medical Care Fresenius Medical Care AG (FMS) Q1 2024 Earnings Call Transcript Broyhill - Fresenius Medical Care: Correctly Focused On Increasing Margins And Returns Fresenius Medical Care AG (FMS) Q4 2023 Earnings Call Transcr...
2024-05-11 03:50:00 ET The healthcare industry is a fantastic place to find passive income. Healthcare is recession-proof, and there's always a need for better technology and new treatments. The industry's top dogs have been in the game for decades and can generate wealth for patient shareh...
2024-05-10 10:16:35 ET More on Eli Lilly, Novo Nordisk, etc. Eli Lilly: Great Time To Divest Before It Potentially Crashes Eli Lilly Remains Expensive Here - Minimal Margin Of Safety The FTC Cracks Down On Novo Nordisk's Ozempic Dividend Roundup: Eli Lilly, A...
2024-05-10 02:08:25 ET Summary iShares MSCI Denmark ETF has $290M in assets and tracks the MSCI Denmark index. EDEN is heavily concentrated in the Health Care sector, with 42% of its assets allocated there. The fund has significant allocations in industrials and financials, an...
News, Short Squeeze, Breakout and More Instantly...
2024-07-17 13:21:54 ET Shares of Swiss pharmaceuticals company Roche Holding (OTC: RHHBY) soared 7% through 11:55 a.m. ET Wednesday on positive data from phase 1 clinical trials of its new weight loss drug CT-996. But good news for Roche is bad news for the companies that no...
2024-07-14 05:20:00 ET Two pharma juggernauts, Novo Nordisk (NYSE: NVO) and Eli Lilly (NYSE: LLY) , are picking up speed in their preparations for an epic battle to control the market for weight loss drugs. The prize for the victor will be a larger market share of what may b...
2024-07-13 17:52:00 ET Novo Nordisk (NYSE: NVO) is already a stock that's easy to justify buying. Between the incredible success of Ozempic, tons of demand for its weight loss medicine, and big investments in manufacturing as well as its pipeline, optimism about its future is practi...